At €26.26 a share, Lakefront Biotherapeutics (LKFT) repurchased 126,322 shares.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Lakefront Biotherapeutics NV repurchased 126,322 ordinary shares between October 5 and October 9, 2026, at an average price of €26.26 per share, totaling €3,317,407.94. This share repurchase was part of a program announced on June 9, 2026. As of October 9, 2026, Lakefront holds 1,877,353 of its own ordinary shares.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.